ArticleArquivos de neuro-psiquiatria2026
Cardiovascular autonomic dysfunction in Parkinson's disease: associations with disease severity and the modulatory role of dopaminergic therapy.
Article in Arquivos de neuro-psiquiatria, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Parkinson's disease (PD) is a complex neurodegenerative disorder characterized by both motor and non-motor symptoms, with autonomic dysfunction significantly impacting patients' quality of life. Despite its recognized importance, comprehensive evaluation of autonomic dysfunction in PD remains limited. Objective: To assess cardiovascular autonomic dysfunction in PD, explore its association with disease severity, and examine the modulatory effects of dopaminergic therapy. Methods: A cross-sectional study was conducted involving 60 PD patients and 30 age- and sex-matched healthy controls. Autonomic function was evaluated using standardized cardiovascular tests, including deep breathing, the Valsalva maneuver, and head-up tilt. Heart rate variability, baroreflex sensitivity, and orthostatic blood pressure responses were measured. Parkinson's disease patients were evaluated in both dopaminergic medication ON and OFF states. Correlations between autonomic parameters and disease severity were analyzed. Results: Parkinson's disease patients demonstrated significant autonomic impairment compared to controls ( Conclusion: Parkinson's disease patients exhibit marked cardiovascular autonomic dysfunction correlating with disease severity. The modest modulatory effects of dopaminergic medication on autonomic parameters suggest complex dopaminergic-autonomic interactions and supports autonomic parameters as potential markers of disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.